Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Diseases, Conditions, Syndromes

Study reveals immune-system paralysis in severe COVID-19 cases

A Stanford study shows that in severely ill COVID-19 patients, "first-responder" immune cells, which should react immediately to signs of viruses or bacteria in the body, instead respond sluggishly.

Immunology

The yin and yang of inflammation controlled by a single molecule

Researchers from the Perelman School of Medicine at the University of Pennsylvania have now identified a protein called histone deacetylase 3 (HDAC3) as the orchestrator of the immune system's inflammation response to infection. ...

page 37 from 40